323 related articles for article (PubMed ID: 15976329)
21. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).
Vossen CY; Conard J; Fontcuberta J; Makris M; VAN DER Meer FJ; Pabinger I; Palareti G; Preston FE; Scharrer I; Souto JC; Svensson P; Walker ID; Rosendaal FR
J Thromb Haemost; 2005 Mar; 3(3):459-64. PubMed ID: 15748234
[TBL] [Abstract][Full Text] [Related]
22. Thrombophilia testing in patients with venous thrombosis.
Caprini JA; Goldshteyn S; Glase CJ; Hathaway K
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):550-5. PubMed ID: 16055356
[TBL] [Abstract][Full Text] [Related]
23. Overweight, obesity, and the risk of recurrent venous thromboembolism.
Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
[TBL] [Abstract][Full Text] [Related]
24. Inherited thrombophilia and pregnancy: the obstetric perspective.
Bonnar J; Green R; Norris L
Semin Thromb Hemost; 1998; 24 Suppl 1():49-53. PubMed ID: 9840692
[TBL] [Abstract][Full Text] [Related]
25. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis.
Wysokinska EM; Wysokinski WE; Brown RD; Karnicki K; Gosk-Beirska I; Grill D; McBane RD
Neurology; 2008 Feb; 70(8):627-33. PubMed ID: 18285537
[TBL] [Abstract][Full Text] [Related]
26. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
[TBL] [Abstract][Full Text] [Related]
27. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
28. Past provoking venous thrombosis risk situations on the risk of a recurrent thrombotic event: a cohort study.
Ribeiro DD; Lijfering WM; Barreto SM; Silva IB; Chalup MM; Rosendaal FR; Rezende SM
Thromb Res; 2011 Sep; 128(3):227-32. PubMed ID: 21600634
[TBL] [Abstract][Full Text] [Related]
29. Recurrent venous thromboembolism in patients with and without anticoagulation after inferior vena caval filter placement.
Yale SH; Mazza JJ; Glurich I; Peters T; Mukesh BN
Int Angiol; 2006 Mar; 25(1):60-6. PubMed ID: 16520726
[TBL] [Abstract][Full Text] [Related]
30. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
[TBL] [Abstract][Full Text] [Related]
31. Cerebral venous thrombosis: analysis of a multicenter cohort from the United States.
Wasay M; Bakshi R; Bobustuc G; Kojan S; Sheikh Z; Dai A; Cheema Z
J Stroke Cerebrovasc Dis; 2008; 17(2):49-54. PubMed ID: 18346644
[TBL] [Abstract][Full Text] [Related]
32. Role of thrombophilia in deciding on the duration of anticoagulation.
Bauer KA
Semin Thromb Hemost; 2004 Dec; 30(6):633-7. PubMed ID: 15630669
[TBL] [Abstract][Full Text] [Related]
33. Extended treatment for venous thromboembolism: how long is long enough?
Cosmi B; Palareti G
Curr Hematol Rep; 2004 Sep; 3(5):375-81. PubMed ID: 15341706
[TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
[TBL] [Abstract][Full Text] [Related]
35. Natural history of mesenteric venous thrombosis in patients treated with vitamin K antagonists: a multi-centre, retrospective cohort study.
Dentali F; Ageno W; Witt D; Malato A; Clark N; Garcia D; McCool K; Siragusa S; Dyke S; Crowther M;
Thromb Haemost; 2009 Sep; 102(3):501-4. PubMed ID: 19718470
[TBL] [Abstract][Full Text] [Related]
36. Reduced inhibition of activated prothrombin by heparin and venous thromboembolism: heparin resistance revisited.
Legnani C; Preda L; Palareti G; Lunghi B; Rossi E; Coccheri S
Haematologica; 2002 Feb; 87(2):182-8. PubMed ID: 11836169
[TBL] [Abstract][Full Text] [Related]
37. Genetic polymorphisms and risk of recurrent deep venous thrombosis in young people: prospective cohort study.
Mansilha A; Araújo F; Severo M; Sampaio SM; Toledo T; Albuquerque R
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):545-9. PubMed ID: 16061406
[TBL] [Abstract][Full Text] [Related]
38. Risk of recurrent venous thomboembolism--expanding the frontier.
Prins MH; Marchiori A
Thromb Haemost; 2002 Jan; 87(1):1-3. PubMed ID: 11848436
[No Abstract] [Full Text] [Related]
39. [Phlebothrombosis and pulmonary thromboembolism in patients with thrombophilia].
Karpenko AA; Gervaziev VB; Barkagan ZS; Tsyvkina LP
Angiol Sosud Khir; 2007; 13(1):59-64. PubMed ID: 17679975
[TBL] [Abstract][Full Text] [Related]
40. Familial thrombophilia: genetic risk factors and management.
Makris M; Rosendaal FR; Preston FE
J Intern Med Suppl; 1997; 740():9-15. PubMed ID: 9350176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
